Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Explore the detailed record of transactions filed by FABRICE VIVIANI, Chief Executive Officer. Officer active across 1 company, notably ONCODESIGN. In total, 2 disclosures have been recorded. Breakdown: 1 buy · 0 sell. Total volume traded: €185k. History available since 18 October 2022. The latest transaction was filed on 14 December 2022 (Acquisition). Regulator: AMF. The full history is free.
2 of 2 declarations
Fabrice Viviani is the Chief Executive Officer of Oncodesign. He is responsible for the strategic and operational leadership of the company, which specializes in developing innovative solutions in oncology. His expertise in management and business development is a significant asset for the expansion and success of Oncodesign in the international market.